Accepted at 8:10 p.m. May, 28, 2024 by Cameron
Author: lawsonspence
Related Note: 1495737396886
Rationale for change

same name but keeps it consistent with amboss plugin

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#Pixorize::03_Pharmacology::12_Oncology_Pharm::07_Busulfan #AK_Step1_v12::#AMBOSS::mpaVJl #AK_Step1_v12::#Low/HighYield::1-HighYield #AK_Step1_v12::#Bootcamp::Pathology::02_Cellular_Injury_&_Neoplasia::11_Cell_Cycle_Independent_Drug_Targets #AK_Step1_v12::#Pixorize::02_Immunology::07_Leukemias_&_Lymphomas::04_Chronic_Myelogenous_Leukemia_(CML) #AK_Step1_v12::#B&B::12_Hematology::04_Cancer_Drugs::02_Alkylating_Agents::Extra #AK_Step1_v12::#OME_banner #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::^Other::^EXPN #AK_Step1_v12::#Bootcamp::Hematology_and_Oncology::08_Principles_of_Oncology_and_Therapeutics::11_Cell_Cycle_Independent_Drug_Targets #PANCE::HEME::neoplasms_premalignancies_malignancies #AK_Step1_v12::#FirstAid::10_Hematology_and_Oncology::05_Pharm::13_Alkylating_agents::*Busulfan #AK_Step2_v12::#SketchyIM::08_Hematology_&_Oncology::04_Oncology::02_Chronic_Leukemias_SOAP #AK_Step1_v12::#SketchyPharm::08_Antineoplastics::02_DNA_&_Cellular_Division::01_Alkylating_Agents::zanki_extra #AK_Step1_v12::#FirstAid::04_Pathology::03_Neoplasia::10_Carcinogens::*Alkylating_Agents::Busulfan